The mid-term outcome of interventricular septal hematoma after ventricular septal defect closure

We present the case report of a patient who developed interventricular septal hematoma as a complication during perimembranous ventricular septal defect closure. Although cardiopulmonary bypass was re-established and the hematoma was aspirated, postoperative echocardiography revealed that the hematoma reaccumulated in the interventricular septum. She suffered from low-cardiac-output syndrome for 1 week requiring a large amount of inotropic agents. Postoperative echocardiography revealed that the interventricular septal hematoma gradually disappeared. At 1 year follow-up, 99mTc-tetrofosmin myocardial single-photon emission computed tomographic revealed myocardial ischemia in the inferior and septal walls. At 4 years follow-up, her cardiac function has gradually improved. She has no symptoms of heart failure with angiotensin-converting enzyme inhibitor and beta-blocker.

Download Full-text

Outcomes of closure of doubly committed subarterial ventricular septal defects in adults

Cardiology in the Young ◽

10.1017/s1047951120000530 ◽

2020 ◽

Vol 30 (5) ◽

pp. 599-606

Author(s):

Zhaoyang Chen ◽

Wanhua Chen ◽

Hang Chen ◽

Zhenmei Liao ◽

Qiang Chen ◽

...

Keyword(s):

Aortic Valve ◽

Ventricular Septal Defect ◽

Aortic Regurgitation ◽

Septal Defect ◽

Intervention Group ◽

Adult Patients ◽

Defect Closure ◽

Ventricular Septal Defect Closure ◽

Sinus Valsalva Aneurysm

AbstractBackground:Outcome data of doubly committed subarterial ventricular septal defect closure in adults are limited.Methods:A review was made of the inpatients >18 years of age who underwent doubly committed subarterial ventricular septal defect closure between June 2010 and June 2017.Results:The patients were categorised into two groups: The valve intervention group consisted of 31 patients who underwent aortic valvuloplasty, aortic valve replacement, or repair of sinus Valsalva aneurysm in addition to doubly committed subarterial ventricular septal defect closure; non-valvular intervention group comprised 58 patients who underwent only doubly committed subarterial ventricular septal defect closure. The groups did not differ by sex and age. Patients in the valve intervention group, with a larger ventricular septal defect size, were shorter and tended to be lighter. The valve intervention group had more patients with pneumonia perioperatively. No infective endocarditis and reoperation were noted during the study period. At last follow-up, 91 and 96.6% of the studied patients were free from left ventricle dilation and pulmonary hypertension. In patients without pre-operative aortic regurgitation, 12 developed new mild aortic regurgitation during the follow-up.Conclusions:About 34.8% of adult patients with doubly committed subarterial ventricular septal defect required concurrent intervention on aortic valve or sinus Valsalva aneurysm. The midterm results of doubly committed subarterial ventricular septal defect closure in adult patients were favourable. However, the incidence of new mild aortic regurgitation after ventricular septal defect closure was high (27.3%). Long-term follow-up of aortic regurgitation progression is needed.

Download Full-text

Mid-term results of percutaneous ventricular septal defect closure with Amplatzer Duct Occluder-II in children

Cardiology in the Young ◽

10.1017/s104795111700107x ◽

2017 ◽

Vol 27 (9) ◽

pp. 1726-1731 ◽

Cited By ~ 4

Author(s):

Ozge Pamukcu ◽

Nazmi Narin ◽

Ali Baykan ◽

Suleyman Sunkak ◽

Onur Tasci ◽

...

Keyword(s):

Ventricular Septal Defect ◽

Septal Defect ◽

Defect Closure ◽

Amplatzer Duct Occluder ◽

Total Procedure Time ◽

Study Centre ◽

Ventricular Septal Defect Closure ◽

The Mean ◽

Mid Term Results

AbstractAimThe aim of this study was to share the mid-term results of percutaneous ventricular septal defect closure using Amplatzer Duct Occluder-II in children.BackgroundNowadays, percutaneous ventricular septal defect closure is accepted as an alternative to surgery, but so far no ideal device has been developed for this procedure.MethodsIn the study centre, between April, 2011 and October, 2016, the ventricular septal defect of 49 patients was closed percutaneously using the Amplatzer Duct Occluder-II device, and seven of them were <1 year old.ResultsThe mean age of patients was 86.8±52.6 months. The mean weight of the patients was 24.3±16 kg. The mean diameter of the defect was 3.7±1.4 mm. Mean fluoroscopy time and total procedure time were 37±19.3 and 74.1±27 minutes, respectively. The types of ventricular septal defects were muscular in six patients, and were perimembranous in the rest of them. We did not face any major complications during the procedure, but one patient was admitted with a complete atrioventricular block in the 6th month of follow-up. The total follow-up period was 66 months.ConclusionTo our knowledge, our study includes the largest series of paediatric patients whose ventricular septal defect was closed using Amplatzer Duct Occluder-II percutaneously. When the complications during the 66-month follow-up period are taken into consideration, we can state that Amplatzer Duct Occluder-II is a safe and effective device, even in infants aged <1 year.

Download Full-text

CLINICAL AND ECHOCARDIOGRAPHIC FOLLOW-UP AFTER SURGICAL VENTRICULAR SEPTAL DEFECT CLOSURE IN ADULTS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(10)60397-x ◽

2010 ◽

Vol 55 (10) ◽

pp. A41.E396

Author(s):

François-Pierre Mongeon ◽

Harold M. Burkhart ◽

Naser M. Ammash ◽

Joseph A. Dearani ◽

Zhuo Li ◽

...

Keyword(s):

Ventricular Septal Defect ◽

Septal Defect ◽

Defect Closure ◽

Ventricular Septal Defect Closure

Download Full-text

Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD Occluder: initial and short-term multi-institutional results

Cardiology in the Young ◽

10.1017/s1047951121002985 ◽

2021 ◽

pp. 1-7

Author(s):

Masood Sadiq ◽

Ahmad Usaid Qureshi ◽

Muhammad Younas ◽

Sohail Arshad ◽

Syed Najam Hyder

Keyword(s):

Ventricular Septal Defect ◽

Aortic Regurgitation ◽

Septal Defect ◽

Defect Closure ◽

Short Term ◽

Ventricular Septal Defect Closure ◽

Coronary Cusp ◽

The Right ◽

Right Coronary Cusp

Abstract Background: Transcatheter ventricular septal defect closure remains a complex procedure with potential complications like complete heart block and aortic regurgitation. The ideal device design for such intervention is still evolving. Aim: To assess the safety, efficacy, and short-term outcome of ventricular septal defect closure using LifeTechTM multifunctional (KONAR-MFTM) VSD Occluder. Patients and methods: In a multicenre study, 44 patients with haemodynamically significant, restrictive ventricular septal defects underwent closure with the KONAR-MFTM device from April, 2019 to March, 2020. Clinical, echocardiographic, and angiographic data were collected and reviewed. Patients were followed up at 1, 3, 6, and 12 months. Results: The median age and weight were 8 (1.7–36) years and 20 (11–79) kg. Of 44 patients, 8 (18%) had a high muscular and 36 (82%) had a perimembranous defect, of which 6 had mild prolapse of the right coronary cusp. The median ventricular septal defect size was 8.8 (3.9–13.4) mm. A retrograde approach was adopted in 39 (88.6%) patients. Nine patients (20.5%) had a small residual leak and there was a slight increase in aortic regurgitation in one patient. One device, which embolised to pulmonary artery was retrieved, and the defect was closed with a larger device. At a median follow-up of 13 (5–18) months, the residual leak persisted in 1 (2.3%) patient. Mild aortic regurgitation in one patient remained unchanged. There were no major complications. Conclusion: Percutaneous closure of ventricular septal defect using KONAR-MFTM device is safe and effective in short and midterm follow-up including selected patients with perimembranous defect and mild prolapse of the right coronary cusp.

Download Full-text